Abcam, ab265368, Human BCL2L2 knockout HeLa cell line

Size: 2 x 1000000Cells / vial / 1000000Cells / vial
BCL2L2 KO cell line available to order. KO validated by Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and Insertion of the selection cassette in exon 3. To order both knockout and wild-type control cells: select 2 x 1000000Cells/vial. To order only knockout cells: select 1000000Cells/vial.
Key facts
Cell type:HeLa,
Species or organism:Human,
Tissue:Cervix,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,Western blot,
Mutation description:Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and Insertion of the selection cassette in exon 3,
Disease:Adenocarcinoma

Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-BCL2L2, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Western blot, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Bcl2L2 also known as Bcl-w is a protein that functions as an anti-apoptotic member of the Bcl-2 family. It has a molecular weight of approximately 21 kDa. This protein is expressed in various tissues such as the brain testis and kidney suggesting it plays a significant role in these organs. Bcl2L2's expression pattern and structure contribute to its function in regulating apoptotic pathways by inhibiting cell death signals.
Biological function summary
The function of Bcl-w involves its role in promoting cell survival. It is part of a complex network of interactions within the Bcl-2 family. This protein family includes both pro-apoptotic and anti-apoptotic proteins and Bcl-w helps maintain the balance by impeding apoptosis. The protein localizes to the mitochondrial outer membrane where it sequesters pro-apoptotic members such as Bax and Bak preventing the release of cytochrome c an essential step in the apoptosis process.
Pathways
The Bcl-w protein integrates into the intrinsic mitochondrial apoptosis pathway. It interacts closely with other Bcl-2 family proteins to ensure cellular homeostasis. Important pathways involving Bcl-w include the mitochondrial or intrinsic apoptosis pathway and the PI3K/AKT signaling pathway both of which regulate cell survival. Related proteins include Bcl-2 Bcl-XL Bax and Bak. These proteins collectively modulate the apoptosis signaling and therefore influence cell fate decisions within tissues where Bcl-w is expressed.
Bcl-w has been implicated in cancer and neurodegenerative diseases due to its role in cell survival and apoptosis regulation. In certain cancers the overexpression of Bcl-w protein can lead to unchecked cell proliferation by avoiding apoptosis therefore promoting tumor growth. In neurodegenerative diseases such as Alzheimer's disease altered expression of Bcl-w may contribute to neuronal survival affecting disease progression. Proteins like Bax and Bak which promote apoptosis are often in regulatory interplay with Bcl-w in these conditions highlighting the delicate balance of pro-survival and pro-apoptotic forces in disease states.